The Government of India (GoI) had announced a Rs 4,500 croreprovisioning to accelerate the production of vaccines Covishield and Covaxin.
Serum Institute decided there and then not to wait for thecash to increase production. It borrowed money from banks to enable the same.
Now, the vaccine Covishield will be sold at Rs 400 per shotto states and Rs 600 per shot to private hospitals. The centre will continue toreceive the same at Rs 150 per shot.
A new round of vaccinations from May 1 to May 18 is anticipatedto require more about 20 lakh more doses per month and Serum Institute hopes toprovide 100 million does after July.
Also, the GoI has stopped exports for the time being tofirst meet the domestic requirements. Adar Poonawalla informs that order isexpected to stand at least till July.
Serum Institute is pursuing the production of the vaccinewith gusto, reaching out to the US President, Joe Biden to lift the embargo onthe export of raw materials. These materials could have a potential affect onthe vaccine Covovax.
Still, alternate suppliers can be arranged but that willtake time.
The American government responded through media that theyacknowledge and understand the concerns. America is probably acting in its bestinterests.
Still, it is comforting to know that India’s vaccine supplyis being looked after by caring individuals and organisations.